MedTrace Logo

Outcomes to the Nutritional Need of Patients With Parkinson's Disease

NCT04983290 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2021-09-28

No results posted yet for this study

Summary

The intervention involves the identification of 140 patients (70 per group), fed throughout the duration of the study with the two different solutions indicated. The subject will be interviewed by identified and trained personnel in order to collect the information and data required by the study with frequency indicated for the individual evaluation sheets. The subject himself will be provided with all the contact and availability information of the referents of the firm for the purpose of requesting information or reporting events. The subject in the studio will be contacted weekly in order to evaluate the trend by the study referents, according to his availability, and personally interviewed by staff belonging to the research group.

Conditions

  • Deglutition Disorders
  • Parkinson Disease
  • Nursing
  • Quality of Life

Interventions

DIETARY_SUPPLEMENT

weancare-domus

Participants belonging to the experimental group will receive at home a set of foods that allows to receive the right amount of proteins and energy in a modified texture form to be prepared by themselves or by their caregivers

Sponsors & Collaborators

  • Azienda Sanitaria Locale 3 Genovese

    collaborator OTHER

  • Milko Zanini

    lead OTHER

Principal Investigators

  • Marina Simonini, Dr · Asl 3 genovese

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2021-12-31
Completion
2022-05-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04983290 on ClinicalTrials.gov